Sugammadex Sodium Patent Expiration

Sugammadex Sodium is Used for reversing drug-induced neuromuscular blockage. It was first introduced by Merck Sharp And Dohme Llc A Sub Of Merck And Co Inc in its drug Bridion on Dec 15, 2015. 5 different companies have introduced drugs containing Sugammadex Sodium.


Sugammadex Sodium Patents

Given below is the list of patents protecting Sugammadex Sodium, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Bridion US6949527 6-Mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block Jan 27, 2021

(Expired)

Msd Sub Merck
Bridion US7265009 HDP-CVD methodology for forming PMD layer Aug 07, 2020

(Expired)

Msd Sub Merck
Bridion US7265099 Use of chemical chelators as reversal agents for drug-induced neuromuscular block Aug 07, 2020

(Expired)

Msd Sub Merck
Bridion USRE44733 6-mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular block Jan 27, 2026 Msd Sub Merck


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Sugammadex Sodium Generics

Several generic applications have been filed for Sugammadex Sodium. The first generic version for Sugammadex Sodium was by Aspiro Pharma Ltd and was approved on Jun 9, 2023. And the latest generic version is by Zydus Pharmaceuticals Usa Inc and was approved on Oct 4, 2023.

Given below is the list of companies who have filed for Sugammadex Sodium generic.


1. SANDOZ

Sandoz Inc has filed for 2 different strengths of generic version for Sugammadex Sodium. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE/2ML (EQ 100MG BASE/ML) solution Prescription INTRAVENOUS AP Jun 23, 2023
EQ 500MG BASE/5ML (EQ 100MG BASE/ML) solution Prescription INTRAVENOUS AP Jun 23, 2023


2. ASPIRO

Aspiro Pharma Ltd has filed for 2 different strengths of generic version for Sugammadex Sodium. Given below are the details of the strengths of this generic introduced by Aspiro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 500MG BASE/5ML (EQ 100MG BASE/ML) solution Prescription INTRAVENOUS AP Jun 9, 2023
EQ 200MG BASE/2ML (EQ 100MG BASE/ML) solution Prescription INTRAVENOUS AP Jun 9, 2023


3. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Sugammadex Sodium. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE/2ML (EQ 100MG BASE/ML) solution Discontinued INTRAVENOUS N/A Oct 4, 2023
EQ 500MG BASE/5ML (EQ 100MG BASE/ML) solution Discontinued INTRAVENOUS N/A Oct 4, 2023


4. MYLAN

Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Sugammadex Sodium. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE/2ML (EQ 100MG BASE/ML) solution Prescription INTRAVENOUS AP Jun 15, 2023
EQ 500MG BASE/5ML (EQ 100MG BASE/ML) solution Prescription INTRAVENOUS AP Jun 15, 2023